IMRX Competitors & Alternatives
Compare Immuneering Corp with similar stocks in the same industry
Biotechnology
IMRX
Main Stock$3.67
Tradestie Score
48
Market Cap
$402.20M
Revenue Growth
-1.0%
Analyst Upside
+363.2%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OMER
Omeros Corporation
|
$17.99
|
$281.75M | 14.9 | 52 | Compare |
|
DBVT
DBV Technologies S.A.
|
$11.43
|
$275.54M | - | 22 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$19.32
|
$269.08M | 0.1 | 47 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$23.90
|
$256.54M | - | 30 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$19.80
|
$240.89M | - | 42 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.95
|
$231.77M | - | 42 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$10.93
|
$227.00M | - | 42 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$8.03
|
$211.22M | - | 60 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$4.00
|
$202.58M | - | 36 | Compare |
More IMRX Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry